Drug Type Small molecule drug |
Synonyms Opigolix (USAN/INN), ASP-1707 |
Target |
Mechanism GnRHR antagonists(Gonadotropin-releasing hormone receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H19F3N4O5S |
InChIKeyCWNLBPBIFALUQD-GFCCVEGCSA-N |
CAS Registry912587-25-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D11351 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 2 | JP | 16 Sep 2016 | |
Pelvic Pain | Phase 2 | JP | 04 Dec 2012 | |
Pelvic Pain | Phase 2 | BE | 04 Dec 2012 | |
Pelvic Pain | Phase 2 | BG | 04 Dec 2012 | |
Pelvic Pain | Phase 2 | DE | 04 Dec 2012 | |
Pelvic Pain | Phase 2 | HU | 04 Dec 2012 | |
Pelvic Pain | Phase 2 | PL | 04 Dec 2012 | |
Pelvic Pain | Phase 2 | RO | 04 Dec 2012 | |
Pelvic Pain | Phase 2 | UA | 04 Dec 2012 | |
Pelvic Pain | Phase 2 | GB | 04 Dec 2012 |